Top Markets
Coin of the day
Diagnocure, Inc. Diagnocure, Inc.

Diagnocure, Inc.

DGCRF
Clasificación en acciones #41417
Diagnocure, Inc. is a Canadian life sciences company dedicated to developing... Diagnocure, Inc. is a Canadian life sciences company dedicated to developing and commercializing innovative products for cancer diagnosis. Its core business revolves around advanced molecular diagnostic tests designed for the identification and management of cancerous conditions. The company's portfolio includes the PCA3 test for prostate cancer diagnosis, as well as the Guanylyl Cyclase C (GCC) marker and the Previstage GCC colorectal cancer staging test, both vital for patients with colorectal cancer. They also offer PCP, a multi-marker diagnostic for prostate cancer. In addition to these tests, Diagnocure provides specialized services such as gene expression and copy number variation analysis, mutation detection, SNP genotyping, and comprehensive platform and laboratory environmental support. Established in 1994 as 9342-8530 Québec Inc. and previously known as DiagnoCure Inc., the company is headquartered in Quebec, Canada.
Precio por acción
$0.0001
Última sincronización: 2025-06-11
Capitalización bursátil
$21.52K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
CA
Comercio Diagnocure, Inc. (DGCRF)

Categoría

Historial del precio de la acción de Diagnocure, Inc. (DGCRF)
Precio más alto de cierre: $0.00 el 2025-06-01

Precio más bajo de cierre: $0.77 el 2012-06-01
Historial del precio de la acción de Diagnocure, Inc. desde 2012 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2025 0.00%
2024 9,900.00%
2022 -99.50%
2021 100.00%
2020 -50.00%
2019 -77.65%
2018 -14.62%
2017 -7.14%
2016 -98.56%
2015 -20.88%
2014 -39.86%
2013 -53.79%
2012 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$236.22 -4.39%
IE
$15.84 -13.29%
CN
$532.45 10.93%
CH
$171.67 -9.77%
CH
$2.37 -28.64%
CN